These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6404528)

  • 21. Comparison of the effects of fermented and unfermented mistletoe preparations on cultured tumor cells.
    Ribéreau-Gayon G; Jung ML; Di Scala D; Beck JP
    Oncology; 1986; 43 Suppl 1():35-41. PubMed ID: 3808575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anthroposophy. Mistletoe preparations: a cancer inhibiting wonder drug?].
    Arm F
    Krankenpfl Soins Infirm; 1989 May; 82(5):18-21. PubMed ID: 2747189
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the tumor-inhibiting efficacy of Iscador in experimental animal tumors.
    Berger M; Schmähl D
    J Cancer Res Clin Oncol; 1983; 105(3):262-5. PubMed ID: 6853588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical investigations with mistletoe (Viscum album L.) extract Iscador.
    Maldacker J
    Arzneimittelforschung; 2006 Jun; 56(6A):497-507. PubMed ID: 16927531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
    Gorter RW; van Wely M; Stoss M; Wollina U
    Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mistletoe (Viscum album L.) extracts Iscador on cell cycle and survival of tumor cells.
    Harmsma M; Ummelen M; Dignef W; Tusenius KJ; Ramaekers FC
    Arzneimittelforschung; 2006 Jun; 56(6A):474-82. PubMed ID: 16927529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R; Sandvig K; Olsnes S
    Oncology; 1988; 45(3):172-9. PubMed ID: 3368193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of tumor growth stimulation in a panel of 16 human tumor cell lines by mistletoe extracts in vitro.
    Maier G; Fiebig HH
    Anticancer Drugs; 2002 Apr; 13(4):373-9. PubMed ID: 11984083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Possibilities and limits of mistletoe therapy in cancer patients].
    Hoffmann J
    Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and identification of a tumour reducing component from mistletoe extract (Iscador).
    Kuttan G; Vasudevan DM; Kuttan R
    Cancer Lett; 1988 Aug; 41(3):307-14. PubMed ID: 3409209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of lung metastasis by adoptive immunotherapy using Iscador.
    Antony S; Kuttan R; Kuttan G
    Immunol Invest; 1999 Jan; 28(1):1-8. PubMed ID: 10073677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
    Büssing A
    Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent response of small cell lung cancer to an extract of mistletoe and homoeopathic treatment.
    Bradley GW; Clover A
    Thorax; 1989 Dec; 44(12):1047-8. PubMed ID: 2559483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
    Wrotek S; Skawiński R; Kozak W
    Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of breast cancer. A comparison between postoperative radiotherapy and long-term iscador treatment following conservative radical mastectomy].
    Koch HL; Voss AC
    Med Welt; 1980 Dec; 31(49):1773-5. PubMed ID: 7207113
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of paramedical treatment methods by cancer patients. A inquiry on 101 ambulatory patients].
    Obrist R; von Meiss M; Obrecht JP
    Dtsch Med Wochenschr; 1986 Feb; 111(8):283-7. PubMed ID: 3081314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Added to conventional therapy, what does mistletoe extract contribute in breast carcinoma].
    MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219134
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.